Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique
- PMID: 22014934
- DOI: 10.1016/j.colsurfb.2011.09.042
Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique
Abstract
Chitosan nanoparticles have been extensively studied for drug and gene delivery. In this paper, monodisperse, low molecular weight (LMW) chitosan nanoparticles were prepared by a novel method based on ionic gelation using sodium tripolyphosphate (TPP) as cross-linking agent. The objective of this study was to solve the problem of preparation of chitosan/TPP nanoparticles with high degree of monodispersity and stability, and investigate the effect of various parameters on the formation of LMW chitosan/TPP nanoparticles. It was found that the particle size distribution of the nanoparticles could be significantly narrowed by a combination of decreasing the concentration of acetic acid and reducing the ambient temperature during cross-linking process. The optimized nanoparticles exhibited a mean hydrodynamic diameter of 138 nm with a polydispersity index (PDI) of 0.026 and a zeta potential of +35 mV, the nanoparticles had good storage stability at room temperature up to at least 20 days.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
-
Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.Colloids Surf B Biointerfaces. 2005 Aug;44(2-3):65-73. doi: 10.1016/j.colsurfb.2005.06.001. Colloids Surf B Biointerfaces. 2005. PMID: 16024239
-
Insight on the formation of chitosan nanoparticles through ionotropic gelation with tripolyphosphate.Mol Pharm. 2012 Oct 1;9(10):2856-62. doi: 10.1021/mp300162j. Epub 2012 Sep 4. Mol Pharm. 2012. PMID: 22845012
-
Chitosan Nanoparticles Prepared by Ionotropic Gelation: An Overview of Recent Advances.Crit Rev Ther Drug Carrier Syst. 2016;33(2):107-58. doi: 10.1615/CritRevTherDrugCarrierSyst.2016014850. Crit Rev Ther Drug Carrier Syst. 2016. PMID: 27651100 Review.
-
Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.Int J Pharm. 2007 May 4;336(1):166-73. doi: 10.1016/j.ijpharm.2006.11.027. Epub 2006 Nov 12. Int J Pharm. 2007. PMID: 17145144
-
Advances in preparation and characterization of chitosan nanoparticles for therapeutics.Artif Cells Nanomed Biotechnol. 2016;44(1):305-14. doi: 10.3109/21691401.2014.948548. Epub 2014 Aug 19. Artif Cells Nanomed Biotechnol. 2016. PMID: 25137489 Review.
Cited by
-
Chitosan Nanoparticles: A Versatile Platform for Biomedical Applications.Materials (Basel). 2022 Sep 20;15(19):6521. doi: 10.3390/ma15196521. Materials (Basel). 2022. PMID: 36233864 Free PMC article. Review.
-
Comparison of the protective effects of CS/TPP and CS/HPMCP nanoparticles containing berberine in ethanol-induced hepatotoxicity in rat.BMC Complement Med Ther. 2024 Jan 15;24(1):39. doi: 10.1186/s12906-023-04318-9. BMC Complement Med Ther. 2024. PMID: 38225618 Free PMC article.
-
Synthesis, Characterization and In Vitro Evaluation of Chitosan Nanoparticles Physically Admixed with Lactose Microspheres for Pulmonary Delivery of Montelukast.Polymers (Basel). 2022 Aug 29;14(17):3564. doi: 10.3390/polym14173564. Polymers (Basel). 2022. PMID: 36080637 Free PMC article.
-
Intranasal Delivery of Genistein-Loaded Nanoparticles as a Potential Preventive System against Neurodegenerative Disorders.Pharmaceutics. 2018 Dec 29;11(1):8. doi: 10.3390/pharmaceutics11010008. Pharmaceutics. 2018. PMID: 30597930 Free PMC article.
-
Neuroprotective and Antioxidant Effect of Naringenin-Loaded Nanoparticles for Nose-to-Brain Delivery.Brain Sci. 2019 Oct 15;9(10):275. doi: 10.3390/brainsci9100275. Brain Sci. 2019. PMID: 31618942 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources